Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Transcriptomic responses of lung mesenchymal cells during pneumonia
Alicia M. Soucy, Jourdan E. Brune, Archana Jayaraman, Anukul T. Shenoy, Filiz T. Korkmaz, Neelou S. Etesami, Bradley E. Hiller, Ian M.C. Martin, Wesley N. Goltry, Catherine T. Ha, Nicholas A. Crossland, Joshua D. Campbell, Thomas G. Beach, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Markus Bosmann, Charles W. Frevert, Joseph P. Mizgerd
Alicia M. Soucy, Jourdan E. Brune, Archana Jayaraman, Anukul T. Shenoy, Filiz T. Korkmaz, Neelou S. Etesami, Bradley E. Hiller, Ian M.C. Martin, Wesley N. Goltry, Catherine T. Ha, Nicholas A. Crossland, Joshua D. Campbell, Thomas G. Beach, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Markus Bosmann, Charles W. Frevert, Joseph P. Mizgerd
View: Text | PDF
Research Article Immunology Pulmonology

Transcriptomic responses of lung mesenchymal cells during pneumonia

  • Text
  • PDF
Abstract

The role of mesenchymal cells during respiratory infection is not well defined, including whether, which, and how the different types of mesenchymal cells respond. We collected all mesenchymal cells from lung single-cell suspensions of mice that were naive (after receiving only saline vehicle), pneumonic (after intratracheal instillation of pneumococcus 24 hours previously), or resolved from infection (after nonlethal pneumococcal infections 6 weeks previously) and performed single-cell RNA sequencing. Cells clustered into 5 well-separated groups based on their transcriptomes: matrix fibroblasts, myofibroblasts, pericytes, smooth muscle cells, and mesothelial cells. Fibroblasts were the most abundant and could be further segregated into Pdgfra+Npnt+Ces1d+Col13a1+ alveolar fibroblasts and Cd9+Pi16+Sca1+Col14a1+ adventitial fibroblasts. The cells from naive and resolved groups overlapped in dimension reduction plots, suggesting the mesenchymal cells returned to baseline transcriptomes after resolution. During pneumonia, all mesenchymal cells responded with altered transcriptomes, revealing a core response that had been conserved across cell types as well as distinct mesenchymal cell type–specific responses. The different subsets of fibroblasts induced similar gene sets, but the alveolar fibroblasts responded more strongly than the adventitial fibroblasts. These data demonstrated diverse and specialized immune activities of lung mesenchymal cells during pneumonia.

Authors

Alicia M. Soucy, Jourdan E. Brune, Archana Jayaraman, Anukul T. Shenoy, Filiz T. Korkmaz, Neelou S. Etesami, Bradley E. Hiller, Ian M.C. Martin, Wesley N. Goltry, Catherine T. Ha, Nicholas A. Crossland, Joshua D. Campbell, Thomas G. Beach, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Markus Bosmann, Charles W. Frevert, Joseph P. Mizgerd

×

Figure 5

PDGFRα+ cell–derived versican does not play a role in inflammation during pneumonia.

Options: View larger image (or click on image) Download as PowerPoint
PDGFRα+ cell–derived versican does not play a role in inflammation durin...
Vcan expression is ablated in sorted (A) PDGFRα+ and (B) PDGFRα– mesenchymal cells from PdgfraCre–ERT2+ Vcantm1.11Cwf (Cre+) but not PdgfraCre–null Vcantm1.11Cwf (Cre–) mice. (C) qRT-PCR analysis of sorted PDGFRα+ and PDGFRα– mesenchymal cells shows that Pdgfra is expressed in cells that do not express surface PDGFRα. (D) Vcan expression is unchanged in sorted alveolar macrophages. Significance was determined by 1-way ANOVA followed by Tukey’s multiple comparisons test (n = 4–5 per treatment group per genotype). (E) Schematic shows the timeline of neutrophil compartmentalization study 24 hours after i.t. S. pneumoniae (created using BioRender). Flow cytometry analysis revealed that (F) airspace and (G) interstitial neutrophil number were not different in Cre– (n = 11) and Cre+ (n = 10) mice. BAL, bronchoalveolar lavage. (H) Edema was not significantly different in lungs of Cre– (n = 9) or Cre+ (n = 7) mice 24 hours after S. pneumoniae. (I) Survival and (J) weight loss after lethal dose of S. pneumoniae and subsequent antibiotic treatment showed that Cre– (n = 5) and Cre+ (n = 8) mice have similar responses to pneumococcal infection. Similarly, H&E staining of lung sections showed no remarkable difference in inflammation or cell infiltration in (K, n = 6) Cre– and (L, n = 5) Cre+ mice. Images representative from 2 separate experiments. Scale bars represent 250 μm. (M) Histological analysis showed no difference in perivascular cuffing or edema. Significance was determined by 2-way ANOVA followed by Holm-Šidák multiple comparisons test. Quantification of versican IHC staining showed no remarkable difference in location of versican in the bronchovascular (N), vascular (O), or alveolar (P) regions. Significance was determined by unpaired t test. All data are mean ± SD; data points are values from individual mice (A–D, F–H, and M–P) or represent the mean (J).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts